:

Homeland Security

NIAID Issues BAA for Bio-Defense Vaccine Enhancement

DDN

Wednesday, October 3rd, 2007

SHARE:

The National Institute of Allergy and Infectious Diseases (NIAID), with funding provided in whole or in part by the Biomedical Advanced Research and Development Agency, plans to fund organizations with demonstrated vaccine product development experience to produce a vaccine candidate either for a NIAID Category A or B Priority Pathogen or a candidate third generation anthrax vaccine. Sol. No. BAA-NIH-BARDA-NIAID-DMID-AI2007007. Respond by Jan. 22, 2008. Contact: Jordan Pulaski, contract specialist, 301-451-480-4675, jpulaski@niaid.nih.gov.

Budget

House Appropriators Uncertain Navy Will Award F/A-XX Contract By August

House appropriators said they are skeptical the Defense Department will award the engineering and manufacturing development (EMD) contract for the Navy’s F/A-XX next-generation carrier-based fighter program by the most recent […]

Congress

House Appropriators Approve $1.07 Trillion FY ‘27 Defense Bill Amid Reconciliation Uncertainty

The House Appropriations Committee has approved its $1.07 trillion fiscal year 2027 defense spending bill, advancing a bill with a historic topline while uncertainty lingers over Congress’ next step to […]

Budget

House Appropriators Add Restrictions And Reporting Requirement To Battleship, Reject Cut

The chairman’s mark of the House Appropriations Committee’s (HAC) fiscal year 2027 defense appropriations bill funds the administration’s $1 billion request for the BBG(X) Trump-class battleship, but adds restrictions requiring […]

Congress

House Appropriators Concerned With ‘Risky’ Reconciliation Approach To Fund Munitions, F-35 Plans

The House Appropriations Committee has raised concern with the Trump administration’s “risky” approach to seeking significant fiscal year 2027 funding for key priorities such as critical munitions and F-35 procurement […]